Abstract
Introduction

36
Long non-coding RNAs (lncRNAs) constitute a relatively unexplored repertoire of gene products 37 that exhibit diverse functions and are involved in several biological processes. As such, the 38 ENCODE consortium reported that 80% of the genome is transcribed into a variety of functional 39 products including non-coding RNAs (Consortium, 2012) . Several high-level characteristics of 
75
Thus, using primarily protein-coding gene expression from microarray to infer the 76 expression of their non-coding counterparts can re-purpose these valuable data and generate 77 novel hypotheses about lncRNAs associated with patient mortality across several cancer types.
78
To this end, multiple studies have attempted to utilize data from microarray to make inferences 79 about lncRNA activity and their clinical relevance. Du et al. re-annotated probes from microarray 80 data to identify prognostic transcriptional activity for ~10,000 lncRNAs in prostate cancer, 81 glioblastoma, ovarian cancer, and lung squamous cell carcinoma (Du et al., 2013) . From this 82 screen, they identified novel lncRNA markers of mortality risk and validated several of them 83 experimentally. Furthermore, Guo et al. performed a "guilt-by-association" analysis whereby
84
lncRNAs that share an edge with prognostic protein coding genes in a biological network defined 85 a priori were also considered prognostic (Guo et al., 2016) .
5
To build upon these studies, we introduce an approach that generates cancer-specific 87 weighted lncRNA regulon network profiles de novo using RNA-seq data from TCGA (The Cancer
88
Genome Atlas), and apply them to infer lncRNA expression in the PRECOG (Gentles et al., 2015) 89 and METABRIC (Curtis et al., 2012) 
106
coding genes composing that lncRNA's regulon. In total, we generated cancer-specific lncRNA 107 regulons for 23 different cancer types using TCGA RNA-seq datasets. Once these regulons were 108 generated, we transformed them into weight profiles and validated their predictive accuracy in
109
TCGA. We then extended our analysis by inferring lncRNA expression in microarray data 110 compendia from PRECOG and METABRIC using the regulon weight profiles and the BASE 111 algorithm (Cheng et al., 2007) . Regulon weight profiles were selected to interrogate microarray 6 data based on matched cancer type. After inferring the expression of thousands of lncRNAs, we 113 performed a systematic pan-cancer screen for prognostic lncRNAs using survival information 
141
Number of lncRNA regulons identified in 23 TCGA cancer types from the ARACne algorithm.
142
Each regulon consists of a lncRNA and its associated protein coding genes B. Distribution of 
9
As an example, the correlation between the inferred and actual expression of HOTAIR and XIST 
156
These results demonstrate that lncRNA expression can be inferred using the expression of protein 
164
Using the METABRIC dataset, we performed hierarchical clustering of the genes using the 
198
Furthermore, we found that some lncRNAs including HOTAIR and H19 were associated 
211
In addition to known cancer-associated lncRNAs, our screen also generated novel 
224
To provide evidence that the identified prognostic lncRNAs are functionally relevant, we 225 performed an integrative analysis of CRISPRi data generated from a high-throughput, systematic 
293
TCGA datasets and observed consistent results ( Figure S2) . In summary, these results indicate 294 that prognostic lncRNAs localize to genomic regions that undergo copy number alteration 295 suggesting that they are under both positive and negative selective pressure by the tumor.
296
To demonstrate that lncRNAs associated with mortality risk are under selection, we 297 highlight JRK and CADM3-AS1. In our analysis of JRK, we discovered that patients with high 298 inferred JRK expression exhibited a higher mortality rate compared to patients with low inferred 299 JRK expression. In conjunction with this result, we also observed higher amplification signal of 
343
In particular, we were able to validate that the inferred lncRNA expression values are 344 accurate and reproducible within and across several datasets. We identified novel associations 345 between lncRNAs and patient mortality risk across 13 (out of 20 total) cancer types that can be 346 further evaluated in more detail. We confirmed that associations between lncRNA expression and 347 mortality risk were consistent regardless of whether inferred or actual expression were used, and
348
showed that prognostic lncRNAs identified in breast and hematopoietic cancers were significantly 
394
Construction of cancer-specific regulons
396
The ARACNe-AP algorithm was applied to each processed TCGA RNA-seq cancer dataset using 
404
The mutual information scores were divided by the maximum score within each regulon so that 
411
Inference of lncRNA expression in microarray datasets
413
For each cancer-specific regulon, we defined a pair of profiles--the genes with a positive weight 414 were assigned to an "up-regulated" profile and the genes with a negative weight were assigned 415 to a "down-regulated" profile. In the up-regulated profile, all genes that had a negative weight
416
were assigned a value of 0 and all genes in the down-regulated profile that had a positive weight
417
were assigned a value of 0. The values in the down-regulated profile were then forced to be 418 positive. Only profiles with 20 or more associated genes were used. Thus, each lncRNA was 419 assigned two regulon weight profiles that captures the magnitude and direction of the genes it 420 was associated with. Genes with higher weights in the two profiles will contribute more to the 421 imputation of lncRNA expression.
423
After constructing the regulon weight profiles, lncRNA expression was inferred in microarray 424 datasets by using the regulon weight profile derived from the same cancer type (or most related 
455
In the PRECOG dataset, there were several microarray datasets belonging to the same 456 cancer type. After computing the inferred expression for all lncRNAs within each dataset, we fitted 457 a univariate Cox regression model to measure the association between a lncRNA and all-cause 458 or disease-specific mortality (if available). z-scores were extracted from the fitted models and a 459 meta z-score was calculated for each lncRNA across all the microarray datasets belonging to the 460 same cancer type. The meta z-score was calculated using weighted Stouffer's z-score method 
500
Essential lncRNAs are defined as those that when knocked down, result in ablation of cell 501 proliferation and cell death and is quantified by a phenotype score included in the dataset.
502
Essential lncRNAs in the MDA-MB-231 (breast) or K562 (hematopoietic) cell lines were selected 503 using an average phenotype score cutoff of <0 and a p-value cutoff of £0. 
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